Evidence map›Paper›PMID 39440302›Full record

ArticleBrain communications2024

Brain network changes after the first seizure: an insight into medication response?

Mangor Pedersen, Heath Pardoe, Remika Mito, Moksh Sethi, David N Vaughan, Patrick W Carney, Graeme D Jackson

Abstract read
In one paragraph

Article in Brain communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Massive Activation of GABABiomolecules · 2025
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mangor PedersenDepartment of Psychology and Neuroscience, Auckland University of Technology (AUT), Auckland 0627, New Zealand.ORCID https://orcid.org/0000-0002-9199-1916
Heath PardoeThe Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne 3010, Australia.ORCID https://orcid.org/0000-0002-0123-2167
Remika MitoThe Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne 3010, Australia.ORCID https://orcid.org/0000-0003-3945-2293
Moksh SethiNeurology Department, Eastern Health, Melbourne 3128, Australia.
David N VaughanThe Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne 3010, Australia.ORCID https://orcid.org/0000-0002-6225-7739
Patrick W CarneyNeurology Department, Eastern Health, Melbourne 3128, Australia.
Graeme D JacksonThe Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne 3010, Australia.ORCID https://orcid.org/0000-0002-7917-5326

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

After a first epileptic seizure, anti-seizure medications (ASMs) can change the likelihood of having a further event. This prospective study aimed to quantify brain network changes associated with taking ASM monotherapy. We applied graph theoretical network analysis to longitudinal resting-state functional MRI (fMRI) data from 28 participants who had recently experienced their first seizure. Participants were imaged before and during long-term ASM therapy, with a mean inter-scan interval of 6.9 months. After commencing ASM, we observed an increase in the clustering coefficient and a decrease in network path length. Brain changes after ASM treatment were most prominent in the superior frontoparietal and inferior fronto-temporal regions. Participants with recurrent seizures display the most pronounced network changes after ASM treatment. This study shows changes in brain network function after ASM administration, particularly in participants with recurrent seizures. Larger studies that ideally include control cohorts are required to understand further the connection between ASM-related brain network changes and longer-term seizure status.

Indexed as

anti-seizure medicationASMfMRInetworksseizures

Identifiers

PMID39440302
PMCPMC11495098

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.